Professional Documents
Culture Documents
ectopic pregnancy
By Nil Goordyal
Contents
Mx of acute ectopic pregnancy
Salpingectomy
Mx of chronic ectopic pregnancy
Mx of unruptured ectopic pregnancy
Expectant management
Medical management
Conservative surgical management
Summary
Management of ectopic
pregnancy
Approach evolved to more conservative medical or
surgical treatment
Type of treatment individualized and depends on
clinical presentation of the patient
Divided into acute, unruptured and subacute
(chronic or old)
Mx of acute ectopic
pregnancy
Principle is resuscitation and laparotomy
Antishock treatment + simultaneous preparation for
urgent laparotomy
Antishock treatment:
1. IV ringer’s solution
2. Arrangement for blood transfusion
3. Volume replacement with colloids (hemacel)
Indication of laparotomy: Hemodynamically unstable,
Laparoscopy CI, evidence of rupture
Approach to laparotomy is “quick in quick out”
Steps of laparotomy
Infraumbilical longitudinal incision
Grasp uterus and draw it up under vision
Tube and ovaries of both sides quickly inspected to
find site of rupture
Salpingectomy; excised tube sent for HPE
Ipsilat ovary and its vascular supply preserved
Place of subtotal hysterectomy: Interstital pregnancy
Mx of chronic ectopic
pregnancy
All cases admitted as emergency
Observation, investigations and patient put up for
laparotomy
Usually pelvic hematocele found
Blood clots removed
Affected tube identified and salpingectomy done
Mx of unruptured
ectopic pregnancy
Expectant
Medical
Surgical
Conservative
Ablative
Expectant Mx
Observation done hoping spontaneous resolution
Indications:
1. Initial serum hCG level < 1000 IU/L and subsequent
falling levels
2. Gestation sac < 4cm
3. No fetal heart beat on TVS
4. No evidence of bleeding or rupture on TVS
Medical Mx
Indications:
• Hemodynamically stable
• Serum hCG less than 3000 IU/L
• Tubal diameter < 4cm without any fetal cardiac
activity
• No intra abdominal hemorrhage
Commonly used drugs: methotrexate, potassium
chloride, PGF2a, hyperosmolar glucose or actinomycin
Systemic therapy: Single dose MTX 50mg/M² IM
Monitoring
Measure serum B-hCG on D4 and D7
When decline in hCG b/w D4 and D7 > or equal to
15%= patient followed up weekly with serum hCG
until hCG < 10 mIU/mL
If decline is less than 15%, second dose of MTX
50mg/M² given on D7
Variable dose MTX
MTX 1mg/kg IM on D1,D3,D5,D7
Leucovorin 0.1mg/kg IM on D2,D4,D6,D8
Serum hCG monitored weekly until < 5.0 mIU/ml
Conservative Surgery
Done either laparoscopically or microsurgical
laparotomy
Indications:
• Cases not fulfilling criteria of medical therapy
• B-hCG not decreasing despite medical therapy
• Persistent fetal cardiac activity
Linear Salpingostomy
• Longitudinal incision on antimesenteric border
• Remove products (by fingers, scalpel handle or
suction)
• Incision line kept open to be healed later
• Hemostasis by eletrocautery or laser
Linear salpingotomy: Incision line closed in two
layers with 7-0 interrupted vicryl sutures (not
commonly done)
Segmental resection
• Choice in isthmic pregnancy
• End to end anastomosis can be done
Fimbrial expression: In cases of distal ampullary
pregnancy and done digitally
Following conservative
surgery
Estimation of B-hCG weekly till value < 5.0 mIU/ml
Additional monitoring by TVS
Persistent ectopic
pregnancy
D/t incomplete removal of trophoblast
High after fimbrial expression
In cases where initial serum B-hCG level > 3000 IU/L
Prophylactic single dose MTX (1mg/kg) IM
References
Dutta Textbook of Obstetrics